Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF
暂无分享,去创建一个
Henrik Zetterberg | Kaj Blennow | Johan Gottfries | Lennart Minthon | Lars Rymo | K. Blennow | L. Minthon | H. Zetterberg | J. Gottfries | A. Simonsen | U. Rüetschi | James McGuire | J. McGuire | V. Podust | H. Davies | Mats Karlsson | Susann Li | L. Rymo | Anja Hviid Simonsen | Ulla Rüetschi | Mats Karlsson | Vladimir N. Podust | Susann Li | Huw Davies | U. Rüetschi | J. Mcguire | M. Karlsson
[1] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[2] M. Rossor,et al. Increased S100β in the cerebrospinal fluid of patients with frontotemporal dementia , 1997, Neuroscience Letters.
[3] P. Deyn,et al. Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF , 1999, Neurology.
[4] Karen Marder,et al. Picking away at frontotemporal dementia. , 2002, Neurology.
[5] M. Riepe,et al. Meningeal derived cerebrospinal fluid proteins in different forms of dementia: is a meningopathy involved in normal pressure hydrocephalus? , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[6] J. E. Jackson. A User's Guide to Principal Components , 1991 .
[7] Tudor I. Oprea,et al. Chemography: the Art of Navigating in Chemical Space , 2000 .
[8] Kaj Blennow,et al. Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients , 2002, Neuroreport.
[9] D. Personett,et al. Septo-hippocampal cholinergic and neurotrophin markers in age-induced cognitive decline , 1998, Neurobiology of Aging.
[10] M. Freedman,et al. Frontotemporal lobar degeneration , 1998, Neurology.
[11] H. Hampel,et al. Total and Phosphorylated Tau Proteins: Evaluation as Core Biomarker Candidates in Frontotemporal Dementia , 2004, Dementia and Geriatric Cognitive Disorders.
[12] K. Blennow,et al. Proteomics for drug target discovery , 2004 .
[13] C. Nilsson,et al. New separation tools for comprehensive studies of protein expression by mass spectrometry. , 2000, Mass spectrometry reviews.
[14] J. Trojanowski,et al. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. , 1997, Biochemical and biophysical research communications.
[15] B. Paterson,et al. Molecular cloning of a gene sequence regulated by nerve growth factor. , 1985, Science.
[16] D. Hochstrasser,et al. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease , 2003, Proteomics.
[17] A Drzezga,et al. Tau and A&bgr;42 protein in CSF of patients with frontotemporal degeneration , 2002, Neurology.
[18] J Gottfries,et al. Diagnosis of dementias using partial least squares discriminant analysis. , 1995, Dementia.
[19] S. Wold. Cross-Validatory Estimation of the Number of Components in Factor and Principal Components Models , 1978 .
[20] M. Rossor,et al. Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease , 1999, Neuroscience Letters.
[21] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[22] K. Blennow,et al. Neurofilament protein levels in CSF are increased in dementia , 1999, Neurology.
[23] K. Blennow,et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization , 2000, Neuroscience Letters.
[24] K. Blennow,et al. Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD , 2000, Neurology.
[25] Frederick E. Petry,et al. Principles and Applications , 1997 .
[26] K. Blennow,et al. Validation of a prefractionation method followed by two-dimensional electrophoresis – Applied to cerebrospinal fluid proteins from frontotemporal dementia patients , 2004, Proteome Science.